Keyphrases
Affinity Chromatography
50%
Binding Antibodies
100%
Commercially Available
50%
Cytopathic Effect
50%
Enzyme-linked Immunosorbent Assay (ELISA)
100%
Interferon-α (IFN-α)
50%
Interferon-β (IFN-β)
100%
Method Validation
50%
Multiple Sclerosis
100%
Neutralizing Antibodies
50%
Optimization Methods
50%
Radioimmunoassay
50%
Relapsing-remitting multiple Sclerosis
50%
Therapeutic Efficacy
50%
Titre
50%
Immunology and Microbiology
Affinity Chromatography
50%
Beta Interferon
100%
Binding Antibody
100%
Cytopathic Effect
50%
Enzyme Immunoassay
100%
Interferon
50%
Multiple Sclerosis
100%
Neutralizing Antibody
50%
Radioimmunoassay
50%
Relapsing Remitting Multiple Sclerosis
50%